In this issue of EMBO Molecular Medicine, Zhao et al, introduce bone morphogenetic protein 9 (BMP9) as a potential therapeutic target for FOP (Zhao et al, 2024). This evidence concerns the gene GDF2 and fibrodysplasia ossificans progressiva.